BNC2 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-68753
Key Product Details
Species Reactivity
Validated:
Human
Predicted:
Mouse (98%), Rat (97%). Backed by our 100% Guarantee.
Applications
Immunocytochemistry/ Immunofluorescence
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
This antibody was developed against a recombinant protein corresponding to amino acids: STQNEYNESSESEVSPTPYKNDQTPNRNALTSITNVEPKTEPACVSPIQNSAPVSDLTKTEHPKSSFRIHRMRRMGSASRKGRVFCNA
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for BNC2 Antibody
Immunocytochemistry/ Immunofluorescence: BNC2 Antibody [NBP2-68753]
Immunocytochemistry/Immunofluorescence: BNC2 Antibody [NBP2-68753] - Staining of human cell line U-251 MG shows localization to nucleoplasm.Applications for BNC2 Antibody
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
0.25-2 ug/ml
Application Notes
ICC/IF Fixation/Permeabilization: PFA/Triton X-100
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS (pH 7.2) and 40% Glycerol
Preservative
0.02% Sodium Azide
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: BNC2
Alternate Names
basonuclin 2, BSN2, DKFZp686A01127, FLJ20043, FLJ34928, zinc finger protein basonuclin-2
Gene Symbol
BNC2
Additional BNC2 Products
Product Documents for BNC2 Antibody
Product Specific Notices for BNC2 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...